MX2021015921A - Injectable preparation. - Google Patents

Injectable preparation.

Info

Publication number
MX2021015921A
MX2021015921A MX2021015921A MX2021015921A MX2021015921A MX 2021015921 A MX2021015921 A MX 2021015921A MX 2021015921 A MX2021015921 A MX 2021015921A MX 2021015921 A MX2021015921 A MX 2021015921A MX 2021015921 A MX2021015921 A MX 2021015921A
Authority
MX
Mexico
Prior art keywords
sup
injectable preparation
composition
present
pascal
Prior art date
Application number
MX2021015921A
Other languages
Spanish (es)
Inventor
Yusuke Hoshika
Takakuni Matsuda
Daiki Kaneko
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Priority to MX2021015921A priority Critical patent/MX2021015921A/en
Publication of MX2021015921A publication Critical patent/MX2021015921A/en

Links

Abstract

An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s<sup>-1</sup> and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s<sup>-1</sup>, as measured.
MX2021015921A 2021-12-16 2021-12-16 Injectable preparation. MX2021015921A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2021015921A MX2021015921A (en) 2021-12-16 2021-12-16 Injectable preparation.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2021015921A MX2021015921A (en) 2021-12-16 2021-12-16 Injectable preparation.

Publications (1)

Publication Number Publication Date
MX2021015921A true MX2021015921A (en) 2023-06-19

Family

ID=90526866

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021015921A MX2021015921A (en) 2021-12-16 2021-12-16 Injectable preparation.

Country Status (1)

Country Link
MX (1) MX2021015921A (en)

Similar Documents

Publication Publication Date Title
US11565022B2 (en) Therapy for post-traumatic osteoarthritis
BR112014026307A2 (en) injectable preparation
WO2018213582A8 (en) Components with high api loading
CY1124225T1 (en) NASAL SPRAY NOZZLE FOR USE IN A MEDICAL SYRINGE
PT1278565E (en) SYRINGE WITHOUT A NEEDLE THAT WORKS WITH A BICOMPOSTA PYROTECHNICAL LOAD
KR102428675B1 (en) Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
JP2005538107A5 (en) Injectable multimodal polymer depot composition and use thereof
JP2015514751A5 (en)
BR0318319A (en) preparation methods and formulations / compositions sustained by the use of dimethicone as a vehicle
BR112015017246A8 (en) aqueous pharmaceutical composition, its use and syringe
CA2649978A1 (en) Lubricious, non-tacky personal lubricant
US20230277432A1 (en) Composition for improving the appearance of ageing skin
CN104888224A (en) Amphipathic polysaccharide derivative/poloxamer thermo-sensitive type in-situ hydrogel and preparation method thereof
MX2021015921A (en) Injectable preparation.
Mahadlek et al. Physical properties and bioactivity of clove oil-loaded solvent exchange-induced in situ forming gel
EP3494970A3 (en) Hardly soluble therapeutic agents belonging to bcs class ii or iv suspended in the liquid formulation and/or in the final nanofibrous structure
IT201800010415A1 (en) Injectable composition comprising hyaluronic acid and trehalose and use of said composition.
EP1308164A3 (en) Medical composition comprising a polysaccharide for elevating the epithelium
CN102755282A (en) Temperature sensitive injectable drug-loading controlled release system
MX2022001374A (en) Pharmaceutical composition for otic administration.
EP4295865A3 (en) Gel compositions and methods of preparation and use thereof
EP1782795A1 (en) Ophthalmic gel made up of triamcinolone acetonide and a polyacrylic polymer
RU2653411C1 (en) Method for producing a therapeutic hydrogel
CN201612739U (en) Dual-property sodium hyaluronate gel medical appliance for ophthalmologic operation
McCoy et al. Development of reservoir vaginal rings containing dapivirine or hormonal contraceptive steroids